BioXcel Therapeutics, Inc. (BTAI) Revenue 2022–2025
BioXcel Therapeutics, Inc. (BTAI) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$642,000FY2025 · since FY2022: $375,000 → $642,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $642,000 | -71.7% |
| FY2024 | $2.3M | +64.2% |
| FY2023 | $1.4M | +268.0% |
| FY2022 | $375,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice